1363 related articles for article (PubMed ID: 24418730)
1. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
[TBL] [Abstract][Full Text] [Related]
2. Pump thrombosis in the Thoratec HeartMate II device: An update analysis of the INTERMACS Registry.
Kirklin JK; Naftel DC; Pagani FD; Kormos RL; Myers S; Acker MA; Rogers J; Slaughter MS; Stevenson LW
J Heart Lung Transplant; 2015 Dec; 34(12):1515-26. PubMed ID: 26681121
[TBL] [Abstract][Full Text] [Related]
3. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
Cowger JA; Romano MA; Shah P; Shah N; Mehta V; Haft JW; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):35-43. PubMed ID: 24418732
[TBL] [Abstract][Full Text] [Related]
4. Hemolysis in left ventricular assist device: a retrospective analysis of outcomes.
Ravichandran AK; Parker J; Novak E; Joseph SM; Schilling JD; Ewald GA; Silvestry S
J Heart Lung Transplant; 2014 Jan; 33(1):44-50. PubMed ID: 24418733
[TBL] [Abstract][Full Text] [Related]
5. Use of left ventricular assist device (HeartMate II): a Singapore experience.
Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
[TBL] [Abstract][Full Text] [Related]
6. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
[TBL] [Abstract][Full Text] [Related]
7. Current risks of HeartMate II pump thrombosis: Non-parametric analysis of Interagency Registry for Mechanically Assisted Circulatory Support data.
Smedira NG; Blackstone EH; Ehrlinger J; Thuita L; Pierce CD; Moazami N; Starling RC
J Heart Lung Transplant; 2015 Dec; 34(12):1527-34. PubMed ID: 26681122
[TBL] [Abstract][Full Text] [Related]
8. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.
Najjar SS; Slaughter MS; Pagani FD; Starling RC; McGee EC; Eckman P; Tatooles AJ; Moazami N; Kormos RL; Hathaway DR; Najarian KB; Bhat G; Aaronson KD; Boyce SW;
J Heart Lung Transplant; 2014 Jan; 33(1):23-34. PubMed ID: 24418731
[TBL] [Abstract][Full Text] [Related]
9. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
[TBL] [Abstract][Full Text] [Related]
10. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
[TBL] [Abstract][Full Text] [Related]
11. PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center study.
Maltais S; Kilic A; Nathan S; Keebler M; Emani S; Ransom J; Katz JN; Sheridan B; Brieke A; Egnaczyk G; Entwistle JW; Adamson R; Stulak J; Uriel N; O'Connell JB; Farrar DJ; Sundareswaran KS; Gregoric I;
J Heart Lung Transplant; 2017 Jan; 36(1):1-12. PubMed ID: 27865732
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of pediatric patients supported by the HeartMate II left ventricular assist device in the United States.
Cabrera AG; Sundareswaran KS; Samayoa AX; Jeewa A; McKenzie ED; Rossano JW; Farrar DJ; Frazier OH; Morales DL
J Heart Lung Transplant; 2013 Nov; 32(11):1107-13. PubMed ID: 24002006
[TBL] [Abstract][Full Text] [Related]
13. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
[TBL] [Abstract][Full Text] [Related]
14. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ;
J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333
[TBL] [Abstract][Full Text] [Related]
15. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.
Tellor BR; Smith JR; Prasad SM; Joseph SM; Silvestry SC
J Heart Lung Transplant; 2014 Jan; 33(1):94-101. PubMed ID: 24418735
[TBL] [Abstract][Full Text] [Related]
16. A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapy.
Katz JN; Jensen BC; Chang PP; Myers SL; Pagani FD; Kirklin JK
J Heart Lung Transplant; 2015 May; 34(5):701-9. PubMed ID: 25582036
[TBL] [Abstract][Full Text] [Related]
17. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
[TBL] [Abstract][Full Text] [Related]
18. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon.
Uriel N; Han J; Morrison KA; Nahumi N; Yuzefpolskaya M; Garan AR; Duong J; Colombo PC; Takayama H; Thomas S; Naka Y; Jorde UP
J Heart Lung Transplant; 2014 Jan; 33(1):51-9. PubMed ID: 24290832
[TBL] [Abstract][Full Text] [Related]
19. Continuous-flow devices and percutaneous site infections: clinical outcomes.
Goldstein DJ; Naftel D; Holman W; Bellumkonda L; Pamboukian SV; Pagani FD; Kirklin J
J Heart Lung Transplant; 2012 Nov; 31(11):1151-7. PubMed ID: 22766022
[TBL] [Abstract][Full Text] [Related]
20. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
